Company Overview and News

CANADA STOCKS-TSX flat as health stocks offset losses in financials

2018-05-18 reuters
May 18 (Reuters) - Canada’s main stock index was trading flat on Friday as a rise in healthcare stocks offset a drop in financial shares after inflation data lifted expectations the central bank will hold interest rates steady later this month.

PRESS DIGEST- Canada - May 18

2018-05-18 reuters
May 18 (Reuters) - The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy.

Aphria strikes deal with wine and spirits supplier Southern Glazer’s for cannabis distribution

2018-05-18 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to:

CANADA STOCKS - TSX rises 0.06 pct, boosted by industrials

2018-05-16 reuters
NEW YORK, May 16 (Reuters) - * The Toronto Stock Exchange’s S&P/TSX rose 10.25 points, or 0.06 percent, to 16,108.06. * The biggest contributor to the TSX gain was Canadian National Railway with 13.3 net index points. The industrials sector was the top contributor with 9.8 net points. * Leading the index were CES Energy Solutions Corp, up 6.0 percent, First Quantum Minerals Ltd, up 5 percent, and West Fraser Timber Co Ltd, higher by 4.

Liberty Health Sciences: U.S. Medical Cannabis Pure Play

2018-05-16 seekingalpha
Vertically integrated business model from "seed to sale" supported by rapid capacity expansion and roll-out of dispensaries.

Scythian Biosciences Announces ColCanna SAS’ Receipt of Licence to Cultivate and Import CBD into Colombia

2018-05-16 globenewswire

CANADA STOCKS - TSX rises 0.08 pct, extends winning streak

2018-05-15 reuters
NEW YORK, May 15 (Reuters) - * The Toronto Stock Exchange’s S&P/TSX rose 12.20 points, or 0.08 percent, to 16,097.81. * The biggest contributor to the TSX gain was Canadian National Railway Co, with 10.1 net index points. Industrials were the top sector contributor with 13 net points. * Leading the index were Element Fleet Management Corp, up 12.1 percent, Aphria Inc, up 7.5 percent, and Boyd Group Income Fund, higher by 4.

30 Marijuana Stocks to Buy as the Future Turns Green

2018-05-14 investorplace
When it comes to cannabis, we’ve come a long way since former President Bill Clinton denied ever inhaling. With the previous presidential administration’s frankness on the matter, marijuana has become more blasé. Naturally, marijuana stocks have also increased in popularity, where we have more choices today than was previously thought possible.

Two Canadian Companies Are Merging in the Biggest Weed Deal Ever - Bloomberg

2018-05-14 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Scythian Biosciences Announces Binding Agreement for Argentinian Acquisition of ABP

2018-05-11 globenewswire
TORONTO, May 11, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that the Company has entered into a business combination agreement (the "Agreement") with MMJ International Investments Inc. (“MMJ” or “MMJ International”), owner of Argentina-based ABP S.A. (“ABP”), a pharmaceutical import and distribution company with a license to import, sell and distribute medical products and derivatives in Argentina.

3 Emerging Industries, 3 Best Companies to Invest In Right Now

2018-05-11 investorplace
Investors wanting the best stocks to invest in right now often dream of finding the investment that was equivalent to buying Microsoft Corporation (NASDAQ:MSFT) in 1986 or Apple Inc. (NASDAQ:AAPL) in 1997 after Steve Jobs returned and began its turnaround. Such investments are difficult to find at those stages. When they become discovered, they do so as they are building an industry of the future.

Is Aphria A Buy Now?

2018-05-11 seekingalpha
2018 Q3 saw solid growth and profitability, prompting us to rate its shares a BUY given the solid execution and growth potential.

Aurora: Q3 2018, Another Solid Quarter Eclipsed By M&A Rumor

2018-05-10 seekingalpha
Revenue grew 38% driven by other revenue outside cannabis sales, which only increased 11% during the quarter.

The BAK Portfolio: Mary Jane Goes To Washington

2018-05-09 seekingalpha
Where the portfolio stood at the time of my last update, where it stands today and recent developments on the stocks held therein.

OrganiGram Holdings: This May Be The Most Undervalued Company In The Cannabis Industry

2018-05-09 seekingalpha
Centralized production facility and rise of cannabis oils as a percentage of sales pushing costs per gram down.

APHQF : Aphria (TSXV:APH) Analysis and Research Report

2017-12-10 - Asif

Aphria Inc., one of Canada’s lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada, Aphria is truly powered by sunlight, allowing for the most natural growing conditions available. Aphria is committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders. Aphria is the first public licenced medical cannabis producer to report positive cash flow from operations and the first to report positive earnings in consecutive quarters. Pure Natures Wellness (PNW), a wholly-owned subsidiary of the Company, is licenced to produce and sell medical marijuana under the provisions of the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). PNW received its licence to produce and sell medical marijuana on November 26, 2014, followed by its licence to sell cannabis extracts on August 18, 2016. PNW’s operations are based in Leamington, ...

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 03765K104